Amarin Corp Plc (AMRN)

[BioChica]

"ADCOM May or may not know about evaporate embargoed results."

Thanks for the info, I was wondering about the reason for EVAPERATE's delayed results. So I'm assuming it will be presented at AHA meeting mid November. No doubt Vascepa plaque reduction played a role in 35% less revascularization, this is an eye opener.